Numerical Pain Score (NPS) Range Zero (minimum) through ten (maximum score) thirty minutes after completion of the treatment session.
| Group | Value | 95% CI |
|---|---|---|
| High Level Pulsed Heat | -1.40 | ± 0.016 |
| Low Level Steady Heat | -0.68 | ± 0.019 |
Last reviewed · How we verify
High Level Pulsed Heat Versus Low Level Steady Heat in Subjects With Chronic Low Back Pain
NA trial testing High Level Pulsed Heat delivered by Generation 5 devices from Soovu Labs Inc. in Chronic Pain in 100 participants. Completed in 25 September 2019.
| Lead sponsor | Soovu Labs Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 June 2019 |
| Primary completion | 1 September 2019 |
| Estimated completion | 25 September 2019 |
| Sites | 1 location across United States |
Soovu Labs Inc. — full company profile →
Adults 21 to 70, any sex, with Chronic Pain or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Numerical Pain Score (NPS) Range Zero (minimum) through ten (maximum score) thirty minutes after completion of the treatment session.
| Group | Value | 95% CI |
|---|---|---|
| High Level Pulsed Heat | -1.40 | ± 0.016 |
| Low Level Steady Heat | -0.68 | ± 0.019 |
Numerical Pain Scale Range Zero (minimum) through ten (maximum score) In this study a lower number on the Numeric Pain Scale means the subject(s) has less pain. Less pain particularly in the experimental group is a better outcome.
| Group | Value | 95% CI |
|---|---|---|
| High Level Pulsed Heat | -1.40 | ± 0.016 |
| Steady Heat Group | -0.68 | ± 0.019 |
This study is a double blinded randomized active placebo controlled trial in subjects with chronic low back pain. The trial compares pain relief by a device that delivered high level pulsed heat (45 °C) to pain relief delivered by a steady heat lower temperature device (37 °C). The hypothesis is that the high temperature pulsed heat device will produce significantly better pain relief as compared to the lower level steady heat device. The secondary hypothesis is that pain relief will occur faster in the high pulsed heat device as compared to the control device.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04109703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing